We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Gene Therapy Protocol at UCSD Activates Immune System in Patients with Leukemia

Researchers report that the patients with CLL who were treated with a gene therapy protocol began making antibodies that reacted against their own leukemia cells.
News

Thermo Scientific LTQ Orbitrap™ Mass Spectrometer Selected for Research in Disease Treatment and Prevention

The Thermo Scientific LTQ Orbitrap was chosen to play a major role in IRCM’s systematic analysis of human protein interaction networks.
News

Quotient BioResearch Acquires BioDynamics

BioDynamics, a specialist provider of metabolism, bioanalytical and radiochemistry services, represents the fourth acquisition to date for Quotient BioResearch.
News

Biomoda and Medical Acoustics Partner in Study for Early Detection of Lung Cancer in Veterans

Biomoda and Medical Acoustics will collect lung sputum samples in an upcoming clinical study that will use Biomoda's proprietary testing technology for detection of early lung cancer.
News

Marshfield Clinic Discovers Gene Variant Which Will Significantly Enhance the Accuracy of Molecular Tests for Warfarin Metabolism

Marshfield Clinic has announced an article published in Blood Online entitled “CYP4F2 genetic variant alters required warfarin dose.”
News

Eisai and Accenture Launch Clinical Data Management in India under Global Outsourcing Agreement

Accenture will provide Eisai with clinical data management services through its delivery center in Chennai, Tamil Nadu, India.
News

KRIBB and Chemizon Announce Collaboration

Chemizon collaborates with KRIBB to spin out a new biotech company designed to commercialize KRIBB’s diverse portfolio of intellectual property assets.
News

Compugen Announces In-Vivo Results for Two Novel Peptide Agonists of MAS GPCR

The two peptides – CGEN-856 and CGEN-857 – were identified using the Company’s previously announced GPCR ligand discovery platform.
News

IBM and University Researchers to Develop Research Tools to Improve Cancer Patient Outcomes

Advanced imaging and computer technologies aimed at providing for reliable prognosis leading to more personalized treatment.
News

Isis Announces $2.8 Million in Government Grants and Contracts Awarded to its Ibis Subsidiary

Ibis has been awarded two new Phase 2 SBIR grants and a new government contract to advance its pathogen identification technology.
Advertisement